Edgar A Borrego

Affiliations: 
2017-2022 Biological Sciences University of Texas at El Paso, El Paso, TX, United States 
Area:
Anti-cancer drug discovery
Google:
"Edgar Borrego"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Edgar A Borrego grad student 2017-2022 UT El Paso

Children

Sign in to add trainee
Edgar A Borrego grad student 2017-2022 UT El Paso
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Huda MN, Borrego EA, Guerena CD, et al. (2023) Topical Administration of an Apoptosis Inducer Mitigates Bleomycin-Induced Skin Fibrosis. Acs Pharmacology & Translational Science. 6: 829-841
Chhikara A, Roayapalley PK, Sakagami H, et al. (2022) Novel Unsymmetric 3,5-Bis(benzylidene)-4-piperidones That Display Tumor-Selective Toxicity. Molecules (Basel, Switzerland). 27
Huda MN, Deaguro IG, Borrego EA, et al. (2022) Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. 349: 783-795
Gutierrez DA, Contreras L, Villanueva PJ, et al. (2022) Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways. Cells. 11
Contreras L, Medina S, Schiaffino Bustamante AY, et al. (2021) Three novel piperidones exhibit tumor-selective cytotoxicity on leukemia cells via protein degradation and stress-mediated mechanisms. Pharmacological Reports : Pr
Lakhani K, Borrego EA, Cano KG, et al. (2021) Design, Syntheses, and Bioevaluations of Some Novel -Acryloylbenzohydrazides as Chemostimulants and Cytotoxic Agents. Medicines (Basel, Switzerland). 8
Meneses-Brassea BP, Borrego EA, Blazer DS, et al. (2020) Ni-Cu Nanoparticles and Their Feasibility for Magnetic Hyperthermia. Nanomaterials (Basel, Switzerland). 10
Donoso-Bustamante V, Borrego EA, Schiaffino-Bustamante Y, et al. (2020) An acylhydroquinone derivative produces OXPHOS uncoupling and sensitization to BH3 mimetic ABT-199 (Venetoclax) in human promyelocytic leukemia cells. Bioorganic Chemistry. 100: 103935
See more...